NYSE · Medical - Distribution
Accendra Health, Inc. (ACH) Stock
$0.44
-6.28%
NYSE: ACH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Accendra Health Announces Leadership Appointments in IT and Procurement
Business Wire · Jul 27, 2026
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
Business Wire · Jul 27, 2026
Accendra Health Files $200 Million Mixed Shelf Registration
MT Newswires · Jul 15, 2026
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds
Insider Monkey · Jul 12, 2026
Is the Options Market Predicting a Spike in Accendra Health Stock?
Zacks · Jul 2, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held7.71%
Institutions Held85.71%
Institutions Float Held92.88%
Peer Comparison
About Accendra Health, Inc.
Accendra Health, Inc. is led by CEO Edward A. Pesicka, employs 23,200 people, headquartered in US, publicly traded since 1980.
Accendra Health, Inc. (ACH) stock trades at $0.44 with a market capitalization of $33.94M. The stock is valued at a price-to-earnings (P/E) ratio of -0.12, price-to-book of -0.07, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.44 and $5.60, and currently trades 92.1% below its 52-week high.
On profitability, Accendra Health, Inc. generates a return on equity (ROE) of 63.40% — well above the market average, a sign of a high-quality business, return on capital employed of 6.65%, an operating margin of 5.43%, a net profit margin of -11.41%.